"Ozempic face" is real, but it's about weight loss, not the drug

What did @globyglen actually say?

Dr. Glen described "Ozempic face" as the loss of collagen or elasticity tied to rapid weight loss, specifically flagging a threshold of five pounds a week. The claim is that when fat pads in the face shrink faster than skin can tighten, you get sagging. The fix, according to the video, is slower weight loss and concurrent regenerative treatments, including platelet-rich plasma (PRP) and a skin-tightening device called NeoGen.

This is a dermatologist-adjacent explanation that sounds clinical, but a few parts of it deserve some scrutiny. The collagen framing in particular is not quite right, and the five-pound-per-week threshold is stated with more confidence than the evidence can actually support.

Does the science back this up?

Partially. The core phenomenon is real, but the mechanism the creator named is off. "Ozempic face" is not primarily about collagen or elasticity loss. It is about fat redistribution and volume loss in specific facial compartments.

Research on facial aging and weight loss consistently shows that the superficial and deep fat compartments of the face, particularly in the mid-face and temporal regions, contribute significantly to facial fullness. When those fat pads shrink rapidly, skin that has not had time to contract visibly sags. This is a fat-volume problem, not a collagen-synthesis problem. Rohrich and Pessa (2007, Plastic and Reconstructive Surgery) mapped these fat compartments and their role in facial aging, and their findings have been applied broadly to weight-loss-related facial changes since then.

There is no published threshold establishing that five pounds per week specifically triggers worse facial changes compared to, say, three pounds per week. That number may come from general clinical experience, but it has not been validated in a controlled study specific to GLP-1 users.

What did they get wrong (or right)?

The creator gets credit for naming the actual driver: fat pad shrinkage. That part is accurate. But describing it as "loss of collagen or elasticity" is a meaningful error. Collagen and elastin are proteins in the dermis. Rapid weight loss does not directly destroy those proteins. What changes is the structural support underneath the skin, specifically the fat volume. Attributing the sagging to collagen loss conflates two different processes and could mislead viewers into thinking they need collagen-stimulating treatments when the real issue is volume replacement.

The recommendation to pursue PRP and NeoGen simultaneously with weight loss is not unreasonable, but it is presented without the caveat that evidence for these treatments in weight-loss-related facial changes specifically is limited. PRP for skin rejuvenation has mixed evidence overall. Alves and Grimalt (2018, Dermatologic Surgery) found modest improvements in skin texture with PRP, but effect sizes were not large and study quality varied.

Recommending both treatments together without noting that outcomes may be modest is a soft form of overselling.

What should you actually know?

"Ozempic face" is a real, documented clinical observation, not a myth. But the mechanism matters if you are trying to address it. Because the primary driver is fat volume loss, not collagen breakdown, the treatments with the strongest evidence for correction are volume-restoring approaches, such as hyaluronic acid fillers or biostimulators like poly-L-lactic acid, which indirectly stimulate collagen but primarily work by restoring structural support.

A 2023 commentary by Atkinson and colleagues in the Journal of Cosmetic Dermatology noted that clinicians are increasingly seeing facial changes in GLP-1 patients and recommended a proactive rather than reactive approach, ideally with a combined strategy. That broadly supports the creator's direction, even if the mechanistic explanation in the video was imprecise.

One thing worth saying plainly: how fast you lose weight on a GLP-1 medication is partly dose-dependent and partly individual. You cannot always control whether you lose two pounds a week or five. If you are experiencing facial changes, talking to both your prescriber and a dermatologist or aesthetic medicine physician is more useful than trying to self-manage the rate of loss.

Is there anything this video is missing?

Yes. The video does not mention that facial changes are more pronounced in older patients, who already have less facial fat and reduced skin elasticity at baseline. Age is a bigger modifier than speed of loss in some patients. It also does not address the option of pausing or adjusting GLP-1 dosing if facial changes are severe, which is a legitimate clinical conversation. And there is no mention of nutrition, particularly protein intake, which some clinicians believe may partially attenuate soft tissue loss during GLP-1-driven weight loss, though the evidence here is still developing.